Feed AMGN
AM

Amgen AMGN · NASDAQ

$460.73 +1.97% (+$8.90)

Market cap
$249.1B
Enterprise value
$292.4B
P/E
28.5x
Forward P/E
19.9x
PEG
0.4x
P/S
6.5x
P/FCF
24.5x
EV/EBITDA
17.7x
ROIC
14.2%
Bruto marža
72.7%
Neto marža
22.9%
Dividend yield
2.16%
Payout ratio
61.5%
Neto dolg/EBITDA
2.6x
Beta
0.41
Free float
99.7%

O podjetju

Amgen Inc. is an American biotechnology company specializing in research, development, and manufacturing of biologic medicines. The company focuses on innovative therapeutic treatments for various diseases, including cancer, cardiovascular conditions, arthritis, and other serious illnesses. Amgen has developed a range of successful drugs that have transformed the lives of patients worldwide. The company also invests in research for new drugs and treatment approaches to better address current and future healthcare challenges. Amgen collaborates with physicians, scientists, and other experts to improve healthcare and develop new therapeutic options. Amgen Inc. (AMGN) shares are an interesting choice for investors who follow the biotechnology sector and seek investment opportunities in a reputable company that brings innovative therapeutic treatments for serious diseases.

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Robert A. Bradway

Employees

31,500

Headquarters

Thousand Oaks

Vrednotenje

Je današnja cena primerna?

  • Na kaj bodite pozorni: Cena delnice je nad Bulios Fair Price.

Rast in ocene

Ali podjetje raste in kaj sledi?

  • Kaj govori v prid: Prihodki so v zadnjih 3 letih rasli za 12 % letno.

Donosnost in kakovost

Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?

  • Kaj govori v prid: Od vsakih 100 USD prihodkov ostane 23 USD čistega dobička.
  • Kaj govori v prid: Na vsakih 100 USD vloženega kapitala zasluži 14 USD letno.

Finančno zdravje

Ali zmore svoj dolg?

  • Na kaj bodite pozorni: Na vsakih 100 USD lastniškega kapitala ima 490 USD dolga.

Kapital in dividende

Kaj podjetje počne z zasluženim denarjem?

  • Kaj govori v prid: Dividendo zvišuje že 14 let zapored.

Analitiki

Kaj menijo strokovnjaki in ali se to spreminja?

Lastniki in insajderji

Kdo ima delnice in kaj počne vodstvo?

Segmenti

Kateri del podjetja raste?

Primerjava s konkurenco

Kako se primerja s podobnimi podjetji?

Cena in tveganje

Kako se delnica obnaša?

Izkazi

Vse številke

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe.